Medication info

Dapagliflozin Propanediol Hydrate 5 mg Tablet

Prescription medicationTabletOral
Ingredient · strength
Dapagliflozin Propanediol Hydrate›6.15mg / 1 tablet
Manufacturer / importer
Kujoo Pharmaceutical Co., Ltd.
Appearance
Yellow round film-coated tablet
Packaging
28 tablets/box [7 tablets/Alu-Alu*4], 28 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202201026 · Approved 2022.03.11

Summary

Main use
Improves blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
Child dose
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Ingredients

Manufacturer
Kujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes mellitus

  • Type 2 diabetes
  • blood sugar irregularities
  • cardiovascular disease
  • cardiovascular risk factors
View approved original text

This medication is used to assist in the control of blood sugar for patients with type 2 diabetes in conjunction with dietary and exercise regimens. It can be used alone or with other medications, and is applicable for patients whose blood sugar is not adequately controlled. It may particularly help prevent cardiovascular events in patients with or at risk for cardiovascular disease. This medication improves blood sugar management and is effective in overall diabetes treatment.

How to take

Adult dose

Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this drug is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, such as insulin. When this drug is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients with no prior history of antidiabetic drug treatment, the recommended initial dose of this drug when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this drug to improve glycemic control is not recommended. - Patients on dialysis: Do not administer this drug. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5 mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This drug may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.

Precautions

This medication should not be administered to specific patients. For example, individuals allergic to any components or additives of this medication, patients with type 1 diabetes or diabetic ketoacidosis, and those undergoing dialysis should not take this medication. Caution should be exercised when using this medication in patients with low fluid volume or impaired renal function. This medication may lower blood pressure or cause temporary changes in renal function, therefore, particular attention is needed in elderly patients with impaired renal function or those taking diuretics. Fluid status and renal function should be evaluated before starting this medication, and during treatment, low blood pressure symptoms and renal function should be monitored closely. The effectiveness of this medication in blood glucose control may vary based on renal function, and in patients with moderate to severe renal impairment, the efficacy in blood glucose control may be reduced. This medication is not recommended for patients with severe renal impairment for blood glucose control purposes. Common side effects that may occur include genital infections and urinary tract infections, which may occur more frequently in women or patients with previous infection experiences. Additionally, symptoms of hypoglycemia may appear, especially when taken with medications that induce hypoglycemia such as insulin or sulfonylureas, necessitating dose adjustments. Dehydration or hypotension may occur due to reduced fluid volume, and in rare cases, serious metabolic disorders such as diabetic ketoacidosis may arise; therefore, careful monitoring for these symptoms is necessary. Ketoacidosis can occur even when blood sugar levels are not elevated, so if symptoms such as nausea, vomiting, abdominal pain, or shortness of breath appear, immediate testing and treatment must be sought. This medication can occasionally cause a serious infection such as Fournier's gangrene; thus, if there is pain, swelling, or redness in the genital or perineal area, immediate medical attention should be sought. Elderly patients or those with impaired renal function should exercise extra caution while taking this medication, especially when combined with diuretics, as the risk of dehydration or hypotension may increase. Pregnant or breastfeeding women should refrain from taking this medication for safety, and if pregnancy is confirmed, they should discontinue use immediately. Patients taking this medication along with insulin or sulfonylureas may need to adjust the doses of these medications to reduce the risk of hypoglycemia. During treatment, fluid status, blood pressure, renal function, blood glucose, and ketone levels should be regularly monitored, and if any unusual symptoms occur, immediate consultation with healthcare professionals is advised. This medication does not affect driving or operating machinery, but caution is needed in cases of hypoglycemia risk. Lastly, the safety and efficacy of this medication have not been established in children, thus it should not be used.

Side effects

Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal gangrene, hypoglycemia, reduced fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, reduced creatinine clearance at the beginning of treatment, dyslipidemia, elevated blood creatinine at the beginning of treatment, elevated blood urea, weight loss, urosepsis, pyelonephritis, acute kidney injury, renal dysfunction, rash, angioedema, gastroesophageal reflux disease, epigastric pain, diverticulosis, bowel perforation, acute pancreatitis, chronic pancreatitis, hyperglycemia, neuropathy, cerebral infarction, nerve compression, sinusitis, diverticulitis, pelvic inflammatory disease, pneumonia, pulmonary tuberculosis, asthenia, pain, ligament sprain, traffic accidents, drug overdose, ankle fracture, hand fracture, iliac bone fracture, meniscus injury, thoracic vertebra fracture, tibia fracture, keratitis, chronic obstructive pulmonary disease, hemoptysis, intracerebral hemorrhage, peripheral artery occlusion, angina pectoris, myocardial infarction, bile duct stones, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, sensory loss, headache, nasopharyngitis, upper respiratory tract infection, chest pain, fatigue, chest discomfort, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, pruritus, urticaria, diaphoresis, arthralgia, musculoskeletal pain, limb pain, myasthenia, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. It should be stored at a temperature between 1 degree and 30 degrees Celsius. This helps to ensure the medication's effectiveness is maintained safely.

Appearance and packaging

Appearance

Yellow round film-coated tablet

Package unit

28 tablets/box [7 tablets/Alu-Alu*4], 28 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.